MDxHealth S.A.
MDXH
Rankning i aktier
#21500
MDxHealth S.A. is a commercial-stage precision diagnostics company that... MDxHealth S.A. is a commercial-stage precision diagnostics company that delivers urological solutions across the United States, the Netherlands, Belgium, Spain, Poland, Italy, the rest of the European Union, and other international markets. They offer innovative genomic testing solutions for prostate cancer, notably the non-invasive SelectMDx urine test and the epigenetic ConfirmMDx test. These advanced tools assist physicians in identifying clinically significant prostate cancer, thus minimizing the need for invasive procedures and their associated complications. Founded in 2003 as OncoMethylome Sciences SA, the company adopted its current name, MDxHealth SA, in October 2010 and is headquartered in Herstal, Belgium.
Aktiekurs
$3.58
Senast synkroniserad: 2023-12-15
Marknadsvärde
$101.57M
Förändring (1 dag)
3.79%
Förändring (1 år)
4.13%
Land
BE
Handel MDxHealth S.A. (MDXH)
Kategori
Healthcare
Historik för aktiesplit för MDxHealth S.A. (MDXH)
Aktien MDxHealth S.A. (symbol: MDXH) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Oct 21, 2026.
En MDXH-aktie köpt före Oct 21, 2026 motsvarar nu 0 MDXH-aktier.
Den senaste spliten skedde den Oct 21, 2026.
En MDXH-aktie köpt före Oct 21, 2026 motsvarar nu 0 MDXH-aktier.
Lista över aktiesplitar
| År | Split | Multipel | Kumulativ multipel |
|---|---|---|---|
| Inte tillräckligt med data för de angivna datumen. | |||
Aktiesplitar för liknande företag eller konkurrenter
| Företag | Antal aktiesplitar | Kumulativ multipel | Land |
|---|---|---|---|
| 8 | x34 |
US
|
|
| 7 | x47 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CN
|
|
| 1 | x1 |
US
|
